{
    "Relevant Biomarkers": [
        {
            "BioMarker": "PR",
            "Method": "IHC",
            "Analyte": "Protien",
            "Result": "Positive| 1+, 1%"
        },
        {
            "BioMarker": "TOP2A",
            "Method": "Seq",
            "Analyte": "DNA-Tumor",
            "Result": "Stable"
        },
        {
            "BioMarker": "MYO1G",
            "Method": "Seq",
            "Analyte": "DNA-Tumor",
            "Result": "Fusion not detected"
        },
        {
            "BioMarker": "ABL1",
            "Method": "Seq",
            "Analyte": "DNA-Tumor",
            "Result": "Stable"
        },
        {
            "BioMarker": "FGFR2",
            "Method": "Seq",
            "Analyte": "DNA-Tumor",
            "Result": "Mutation not detected"
        }
    ],
    "Genomic Signatures": [
        {
            "BioMarker": "Microsatellite instability",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Result": "Equivocal"
        },
        {
            "BioMarker": "Tumor mutational burden",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Result": "12 mutations/Mb Low"
        },
        {
            "BioMarker": "Genomic loss of heterozygosity (LOH)",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Result": "Low - 4% of tested genmoic segments exhibit LOH"
        }
    ],
    "Genes Tested with Pathogenic Alterations": [
        {
            "Gene": "CTNNB1",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Pathogenic",
            "Protien Alteration": "p.A169T",
            "Exon": 15,
            "DNA Alteration": "c.505G>A",
            "Allele Frequency %": "22.31"
        },
        {
            "Gene": "ALDH2",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Benign",
            "Protien Alteration": "p.R479H",
            "Exon": 14,
            "DNA Alteration": "c.1436G>A",
            "Allele Frequency %": "28.56"
        },
        {
            "Gene": "ARID2",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Likely Pathogenic",
            "Protien Alteration": "p.P95X",
            "Exon": 17,
            "DNA Alteration": "1",
            "Allele Frequency %": "2.49"
        },
        {
            "Gene": "KLF4",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Benign",
            "Protien Alteration": "p.H598T",
            "Exon": 20,
            "DNA Alteration": "c.1792C>T",
            "Allele Frequency %": "23.64"
        },
        {
            "Gene": "ALK",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Likely Pathogenic",
            "Protien Alteration": "p.T367N",
            "Exon": 20,
            "DNA Alteration": "c.1100C>A",
            "Allele Frequency %": "1.08"
        },
        {
            "Gene": "EGFR",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Benign",
            "Protien Alteration": "p.W515L",
            "Exon": 17,
            "DNA Alteration": "c.1544G>T",
            "Allele Frequency %": "2.29"
        }
    ]
}